Targeted Delivery of BZLF1 to DEC205 Drives EBV-Protective Immunity in a Spontaneous Model of EBV-Driven Lymphoproliferative Disease

Epstein-Barr virus (EBV) is a human herpes virus that infects over 90% of the world’s population and is linked to development of cancer. In immune-competent individuals, EBV infection is mitigated by a highly efficient virus-specific memory T-cell response. Risk of EBV-driven cancers increases with...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmed, Elshafa Hassan, Brooks, Eric, Sloan, Shelby, Schlotter, Sarah, Jeney, Frankie, Hale, Claire, Mao, Charlene, Zhang, Xiaoli, McLaughlin, Eric, Shindiapina, Polina, Shire, Salma, Das, Manjusri, Prouty, Alexander, Lozanski, Gerard, Mamuye, Admasu T., Abebe, Tamrat, Alinari, Lapo, Caligiuri, Michael A., Baiocchi, Robert A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8228306/
https://www.ncbi.nlm.nih.gov/pubmed/34073261
http://dx.doi.org/10.3390/vaccines9060555

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8228306/
https://www.ncbi.nlm.nih.gov/pubmed/34073261
http://dx.doi.org/10.3390/vaccines9060555

Ejemplares similares